Jeena Sikho LifecareNSE:JSLL +3.81%91 Return-on-Tangible-Equity is 44.51% as of Mar. 2026, which is 8% below its 10-year median of 48.42. GuruFocus rates NSE:JSLL with a GF Score™ of 91/100 and a GF Value™ of ₹771.54 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 581 Healthcare Providers & Services companies, Jeena Sikho Lifecare ranks better than 85.03% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Jeena Sikho Lifecare's annualized net income for the quarter that ended in Mar. 2026 was ₹1,805 Mil. Jeena Sikho Lifecare's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ₹4,056 Mil. Therefore, Jeena Sikho Lifecare's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 44.51%.
The historical rank and industry rank for Jeena Sikho Lifecare's Return-on-Tangible-Equity or its related term are showing as below:
NSE:JSLL'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 37.27 Med: 48.42 Max: 75.74
Current: 73.46
During the past 8 years, Jeena Sikho Lifecare's highest Return-on-Tangible-Equity was 75.74%. The lowest was 37.27%. And the median was 48.42%.
NSE:JSLL's Return-on-Tangible-Equity is ranked better than 85.03% of 581
companies
in the Healthcare Providers & Services industry
Industry Median: 9.93
vs NSE:JSLL: 73.46
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Jeena Sikho Lifecare Return-on-Tangible-Equity Related Terms
Jeena Sikho Lifecare Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Jeena Sikho Lifecare's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:JSLL vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, Jeena Sikho Lifecare's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jeena Sikho Lifecare Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Jeena Sikho Lifecare's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Jeena Sikho Lifecare's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 44.51% mean?
Jeena Sikho Lifecare (NSE:JSLL) has a Return-on-Tangible-Equity of 44.51% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Jeena Sikho Lifecare and its competitors. This is near median its historical median of 48.42. Over the past decade, Jeena Sikho Lifecare's Return-on-Tangible-Equity has ranged from 37.27 to 75.74. According to the industry distribution chart, Jeena Sikho Lifecare ranks #87 out of 581 companies in the Healthcare Providers & Services industry, placing it in the top 15%.
Is Jeena Sikho Lifecare's Return-on-Tangible-Equity too high?
Jeena Sikho Lifecare's current Return-on-Tangible-Equity of 44.51% is near median its 10-year median of 48.42. Over the past 10 years, this metric has ranged from a low of 37.27 to a high of 75.74. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 9.93. Jeena Sikho Lifecare's value of 44.51% is 348.2% above this industry median. Based on the distribution chart, Jeena Sikho Lifecare ranks #87 out of 581 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Jeena Sikho Lifecare has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jeena Sikho Lifecare's Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Jeena Sikho Lifecare ranks #87 out of 581 companies for Return-on-Tangible-Equity. This places Jeena Sikho Lifecare in the top 15% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 9.93. Jeena Sikho Lifecare's value of 44.51% is 348.2% above this benchmark. Historically, Jeena Sikho Lifecare's own Return-on-Tangible-Equity has ranged from 37.27 to 75.74 over the past decade. While the company's 10-year median is 48.42 vs. the industry median of 9.93, Jeena Sikho Lifecare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 9.93, based on 581 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jeena Sikho Lifecare's current Return-on-Tangible-Equity of 44.51% is 348.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Jeena Sikho Lifecare and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 9.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jeena Sikho Lifecare's current Return-on-Tangible-Equity is 44.51%, which is near median its own 10-year median of 48.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jeena Sikho Lifecare stock overvalued right now?
Based on GuruFocus' analysis, Jeena Sikho Lifecare (NSE:JSLL) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹771.54, compared to a current price of ₹602.25 — trading 21.9% below its estimated fair value. The current Return-on-Tangible-Equity is 44.51%, which is near median its 10-year median of 48.42 and 348.2% above the Healthcare Providers & Services industry median of 9.93. Jeena Sikho Lifecare's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Jeena Sikho Lifecare (NSE:JSLL), the current Return-on-Tangible-Equity is 44.51% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jeena Sikho Lifecare (NSE:JSLL) Overvalued in 2026?
Based on GuruFocus' analysis, Jeena Sikho Lifecare stock appears to be undervalued.
The current stock price of ₹602.25 is trading 21.9% below its estimated GF Value™ of ₹771.54.
GuruFocus considers Jeena Sikho Lifecare to be Modestly Undervalued.
Key valuation signals for NSE:JSLL:
Return-on-Tangible-Equity: 44.51% (near median its 10-year median of 48.42)
GF Value™: ₹771.54 vs. price of ₹602.25 (21.9% below fair value)
Industry Position: 348.2% above the Healthcare Providers & Services median (#87 of 581)
No single metric tells the full story. See the NSE:JSLL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jeena Sikho Lifecare Ltd provides Ayurvedic healthcare products and services. The company operates only in one business segment which is Trading of Ayurvedic Medicines and providing Ayurvedic therapies. The company engages in conducting health check-up camps, and free yoga sessions to make people aware of health problems. It offers a wide range of Ayurvedic products such as Shuddhi 32 Herbs Tea, Shuddhi Addiction Free Kit, Shuddhi BP Package, Shuddhi Diabetes Care Package, and Shuddhi Divya Sanjeevani-Anti-Viral Package.
91GF Score
Get the complete analysis for NSE:JSLL
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:JSLL has been successfully added to your 
